Quest Diagnostics 2007 Annual Report Download - page 115

Download and view the complete annual report

Please find page 115 of the 2007 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
EXHIBITS TO FORM 10-K
For the fiscal year ended December 31, 2007
Commission File No. 001-12215
QUEST DIAGNOSTICS INCORPORATED
Exhibit
Number Description
3.1 Restated Certificate of Incorporation (filed as an Exhibit to the Company’s current report on Form 8-
K (Date of Report: May 31, 2001) and incorporated herein by reference) (Commission File Number
001-12215)
3.2 Amendment of the Restated Certificate of Incorporation (filed as an Exhibit to the Company’s
quarterly report on Form 10-Q for the quarter ended June 30, 2006 and incorporated herein by
reference)
3.3 Amended and Restated By-Laws of the Registrant (filed as an Exhibit to the Company’s current
report on Form 8-K (Date of Report: March 28, 2007) and incorporated herein by reference)
4.1 Form of 7
1
⁄
2
% Senior Note due 2011, including the form of guarantee endorsed thereon (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: June 27, 2001) and
incorporated herein by reference) (Commission File Number 001-12215)
4.2 Form of 5.125% Exchange Senior Note due 2010, including the form of guarantee endorsed thereon
(filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: November 1,
2005) and incorporated herein by reference)
4.3 Form of 5.45% Exchange Senior Note due 2015, including the form of guarantee endorsed thereon
(filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: November 1,
2005) and incorporated herein by reference)
4.4 Form of 6.40% Senior Note due 2017, including the form of guarantee endorsed thereon (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: June 19, 2007) and
incorporated herein by reference)
4.5 Form of 6.95% Senior Note due 2037, including the form of guarantee endorsed thereon (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: June 19, 2007) and
incorporated herein by reference)
4.6 Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and the Trustee
(filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: June 27, 2001)
and incorporated herein by reference) (Commission File Number 001-12215)
4.7 First Supplemental Indenture, dated as of June 27, 2001, among the Company, the Subsidiary
Guarantors, and The Bank of New York (filed as an Exhibit to the Company’s current report on Form
8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number
001-12215)
4.8 Second Supplemental Indenture, dated as of November 26, 2001, among the Company, the Subsidiary
Guarantors, and The Bank of New York (filed as an Exhibit to the Company’s current report on Form
8-K (Date of Report: November 26, 2001) and incorporated herein by reference) (Commission File
Number 001-12215)
4.9 Third Supplemental Indenture, dated as of April 4, 2002, among the Company, the Additional
Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company’s current
report on Form 8-K (Date of Report: April 1, 2002) and incorporated herein by reference)
(Commission File Number 001-12215)
4.10 Fourth Supplemental Indenture dated as of March 19, 2003, among Unilab Corporation (f/k/a Quest
Diagnostics Newco Incorporated), the Company, The Bank of New York, and the Subsidiary
Guarantors (filed as an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended
March 31, 2003 and incorporated herein by reference)
4.11 Fifth Supplemental Indenture dated as of April 16, 2004, among Unilab Acquisition Corporation (d/b/a
FNA Clinics of America), the Company, The Bank of New York, and the Subsidiary Guarantors (filed
as an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2004
and incorporated herein by reference)
4.12 Sixth Supplemental Indenture dated as of October 31, 2005, among the Company, The Bank of New
York, and the Subsidiary Guarantors (filed as an Exhibit to the Company’s current report on Form 8-
K (Date of Report: October 31, 2005) and incorporated herein by reference)
4.13 Seventh Supplemental Indenture dated as of November 21, 2005, among the Company, The Bank of
New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company’s current report on
Form 8-K (Date of Report: November 21, 2005) and incorporated herein by reference)
E-1